C - Chemistry – Metallurgy – 12 – N
Patent
C - Chemistry, Metallurgy
12
N
C12N 15/45 (2006.01) A61K 9/00 (2006.01) A61K 31/7105 (2006.01) A61K 31/713 (2006.01) A61K 48/00 (2006.01) A61P 31/12 (2006.01) C07H 21/02 (2006.01) C12N 15/33 (2006.01) C12N 15/41 (2006.01) C12N 15/44 (2006.01) C12Q 1/68 (2006.01) C12Q 1/70 (2006.01)
Patent
CA 2603842
Disclosed herein is a double stranded siRNA molecule that inhibits production of a respiratory virus, wherein each strand of said siRNA molecule is about 15 to about 50 nucleotides, and wherein one strand of said siRNA molecule comprises a nucleic acid sequence identical to a conserved site, or a variant thereof, within the nucleic acid sequence of the respiratory virus, and uses thereof.
L'invention concerne une molécule d'ARNsi à double brin inhibant la production d'un virus respiratoire, chaque brin de la molécule d'ARNsi comprend entre environ 15 et environ 50 nucléotides et un brin de la molécule d'ARNsi comprend une séquence d'acide nucléique identique au site conservé, ou une variante, dans la séquence d'acide nucléique du virus respiratoire. L'invention concerne également les utilisations associées.
Ge Qing
Kumar Mukesh
Mcswiggen James Anthony
Borden Ladner Gervais Llp
Marina Biotech Inc.
Nastech Pharmaceutical Company Inc.
LandOfFree
Rnai therapeutic for respiratory virus infection does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Rnai therapeutic for respiratory virus infection, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Rnai therapeutic for respiratory virus infection will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1389859